In case you’re not familiar with it, walking pneumonia is a respiratory infection that's usually caused by Mycoplasma ...

Jolanda Howe, the SVP of $MIRM, sold 2,415 shares of the company on 03-18-2025 for an estimated $107,342. We received data on the trade from a recent SEC filing. This ...

Shares of NASDAQ MIRM opened at $46.08 on Tuesday. The stock has a fifty day moving average of $48.03 and a 200-day moving average of $43.82. The stock has a market cap of $2.26 billion, a PE ...

J.P. Morgan analyst Jessica Fye maintained a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report) today and set a price target of $53.00. The company’s shares closed yesterday at $43.23.